This study was funded by GlaxoSmithKline.
The study was conducted by a physician who is a consultant for GlaxoSmithKline.
Dutasteride REDUCE Trial
April 29, 2009 by underwritingsolutionsllc
Posted in Cancer, Clinical Trials, Medical News, underwriting | Tagged Cancer, Lifelong Learning, pharmaceutical, prostate cancer, underwriting | No Comments Yet
-
Recent Posts
-
Top Posts
Archives
Pages
About
AHA Journals
Alltop Websites
Anatomy
Bankruptcy Basics
Blogroll
Cancer
Cardiovascular
Classic References Online
diabetes
Drug Abuse
Health Data and Statistics
Hepatitis
Hypertension
Jobs
Lifestyle
Management
Medical Abbreviations
Medical News - General
Nutrition and Diet
Obesity
occupational risk
Pictures
Psychology
Public Health
Read a Book a Week
Small Business
Category Cloud
accidents Business Trends Cancer CHD Clinical Trials diabetes Insurance News International Risk Jobs Journal Scan Lifelong Learning Life Settlements Lifestyle Underwriting Listen and Learn Medical News Medical tourism Mice Abuse Nutrition occupational risk Pharma Populuaton Studies Question of The Day Remote Underwriting Success Survival strategies Thought For Today Travel Risk Uncategorized underwriting Watch Listen and LearnTags
alcohol all-cause mortality atrial fibrillation business business success CAD Cancer CHF cholesterol depression diabetes Diet do what you love exercise FME HTN India infectious diseases Lifelong Learning Lifestyle LinkedIn Mexico NaBloPoMo09 outsourcing personal success pharmaceutical prostate cancer Read a Book a Week Remote Underwriting Scary Charts self improvement Statins stenting Stroke risk Success SUDDEN CARDIAC DEATH Suicide swine flu technology support Telecommute telecommuting Travel Risk underwriting Vitamin D weight lossMeta
